LDN Social Media
Get connected with us on social networks
Effect of Low-Dose Naltrexone on Egyptian Children with Intractable Epilepsy: A Case Series Study
Neurol India
23 December 2021
https://www.neurologyindia.com/article.asp?issn=0028-3886;year=2021;volume=69;issue=6;spage=1781;epage=1784;aulast=Abokrysha
Epilepsy is a chronic neurological disorder affecting 50 million patients worldwide, in need of continuous treatment, while 30% of them are refractory to treatment. Despite multiple antiepileptic drugs are available for the treatment of epilepsy, still refractory epilepsy especially in children represents a social burden in developing countries. Low-dose naltrexone (LDN) has been proposed as an immune modulator in multiple diseases and proved benefit especially in diseases with immune dysregulation. The purpose of this study is to demonstrate the effect of LDN in the treatment of children with intractable epilepsy and discuss its potential role in epileptogenesis process.
Keywords: Children, intractable epilepsy, low-dose naltrexone, treatment